Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say
Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized…
Read MoreMerck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized…
Read MoreElon Musk filed a motion Friday opposing Twitter Inc.’s request to expedite a trial over…
Read MoreElon Musk filed a motion Friday opposing Twitter Inc.’s request to expedite a trial over…
Read MoreAs the SPAC boom was beginning to rage two years ago, this column asked why…
Read MorePayments giant Stripe, last valued by private investors at $95 billion, cut the internal value…
Read MoreAmazon.com Inc. has started drastically reducing the number of items it sells under its own…
Read MoreHoward Kornstein, a professional trader with more than 40 years’ experience in stocks, options and…
Read MoreHi, MarketWatchers. Don’t miss these top stories. The solution to the labor shortage in construction?…
Read MoreActivist investor Elliott Management Corp. has taken a big stake in Pinterest Inc., according to…
Read More
Weekend reads: What you can do to counter high inflation
This week featured another batch of government reports underlining the high inflation Americans are suffering…
Read More